Table 2. Participating caregivers’ (N=66) access to allergy-related care, including type of delivery, during the COVID-19 pandemic
Type of care Satisfaction Satisfaction
n % mean SD
A. Allergy-related care*
Initial assessment 22 33.3 72.5 24.4
Follow-up 50 75.8 78.0 27.2
Early introduction 3 4.5 89.3 9.5
Oral food challenge 18 27.3 77.9 27.3
Oral immunotherapy 14 21.2 87.4 26.4
B. Allergy-related care by type of delivery B. Allergy-related care by type of delivery B. Allergy-related care by type of delivery
Initial assessment
Virtual 12 54.5 66.5 27.6
In-person 7 31.9 81.1 14.2
Both 3 13.6 76.3 30.7
Follow-up
Virtual 35 70.0 75.2 29.6
In-person 14 28.0 83.6 20.3
Both 1 2.0 97.0 -
Early introduction
Virtual 3 100.0 89.3 9.5
In-person 0 0.0 - -
Both 0 0.0 - -
Oral food challenge
Virtual 16 88.9 76.0 28.5
In-person 0 0.0 -
Both 2 11.1 93.0 1.4
Oral immunotherapy
Virtual 8 57.1 91.5 9.8
In-person 0 0.0 0.0 0.0
Both 6 42.9 82.0 40.2
Not mutually exclusive
Abbreviation: SD Standard deviation Abbreviation: SD Standard deviation Abbreviation: SD Standard deviation